FORMELA JEAN FRANCOIS sold $30K of KRRO (indirect holdings)
FORMELA JEAN FRANCOIS sold 2,143 indirectly-held shares of Korro Bio, Inc. (KRRO) at $13.96 across 2 trades on 2026-08-11 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosed open-market sale by a director can be monitored for sentiment, but the presence of a pre-arranged 10b5-1 plan typically lowers interpretive weight.
Market read
Traders may treat this as a minor sentiment datapoint rather than a standalone fundamental catalyst.
What to watch
The article does not disclose total insider ownership changes beyond the post-transaction share count, nor does it provide context on prior sales frequency.
Background
The article is a SEC Form 4 insider transaction disclosure for Korro Bio, Inc.
Ticker impact
Korro Bio director Formela Jean Francois sold $29,916 of KRRO via an open-market sale under a pre-arranged 10b5-1 plan.
Likely limited near-term impact; any effect would be incremental sentiment rather than a directional driver.
The filing is a Form 4 insider transaction with a stated 10b5-1 plan, which typically reduces the signal strength versus discretionary selling.
Market effects
No clear sector read-through from a single director 10b5-1 sale.
None indicated.
None indicated.
Counterpoint
Because the sale is under a pre-arranged 10b5-1 plan, it may reflect liquidity planning rather than bearish expectations.
Key entities
- issuerKorro Bio, Inc.
Company whose director insider sale is disclosed on Form 4.
- insiderFORMELA JEAN FRANCOIS
Director who executed an open-market sale under a 10b5-1 plan.
